Tranexamic acid (TXA) has been used off-label in many surgical fields to reduce bleeding and ecchymosis.
However, given its theoretical thrombotic potential, it has not been widely used in breast cancer patients.
The goal of this study was to prospectively evaluate the utility of topical TXA in postmastectomy breast reconstruction patients.
